Other languages Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Delayed NSE India S.E. Other stock markets 04:43:56 2024-05-15 EDT			5-day change	1st Jan Change
721.8 ^INR	+4.89%		+3.03%	+31.82%

05-03	Jubilant Pharmova Appoints CEO for Radiopharma Business	MT
04-25	Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jubilant Pharmova Appoints CEO for Radiopharma Business	05-02
Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	04-24
India's Jubilant Pharmova posts quarterly profit	02-02
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-02
Jubilant Pharmova Limited Announces the Resignation of Kumar Ramamurthi as Director and Whole-Time Director, Effective October 31, 2023	23-10-27
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-27
Domino's India operator Jubilant beats Q2 profit estimates on cheaper launches	23-10-25
Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2023, Payable on or Before September 29, 2023	23-08-07
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23-07-31
Jubilant Pharmova's Consolidated Profit Plunges in Fiscal Q1	23-07-20
Jubilant Pharmova Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-19
Indian shares set for flat start ahead of key earnings	23-07-18
Late Rally Led by Consumer Goods, Financials Lifts Indian Equities to Close Higher	23-05-30
Jubilant Pharmova Limited Announces Change in Directorate	23-05-30
INDIA STOCKS-Indian shares rise to five-month high on improved global cues	23-05-30
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23-05-29
Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29
Jubilant Pharmova Limited Appoints Shirish G. Belapure as Additional Director (Non-Executive, Independent)	23-03-08
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-03
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Other languages

Filters